CYCN
Cyclerion Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.25
−14.31%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 5.17x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.91x
- Price / sales
- 10.47x
- Price / cash flow
- -4.47x
Enterprise value
- Enterprise value
- $18.5M
- EV / sales
- 9.74x
- EV / EBITDA
- -2.76x
- EV / EBIT
- -2.71x
- Market cap
- $19.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026